Benign cyclic breast lumpiness and tenderness — extremely common; reassurance after exclusion of malignancy.
Also known as: fibrocystic breast disease, fibrocystic changes, breast cysts, benign breast disease
Overview
Constellation of benign, hormonally responsive changes in the breast — stromal fibrosis, cyst formation, ductal hyperplasia, and apocrine metaplasia — producing nodularity and cyclic discomfort. No longer considered a 'disease.'
Epidemiology
Most common benign breast condition; affects ~50-60% of reproductive-age women. Peak incidence ages 30-50. Usually subsides after menopause unless on hormone therapy.
Try two board-style Fibrocystic Breast Changes questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveMedium
A 34-year-old woman presents with bilateral breast tenderness and lumpiness that she notices most in the upper outer quadrants. The discomfort worsens in the week before her menstrual period and improves once bleeding begins. On examination, both breasts have a diffuse, ropy, cobblestone texture with a few tender areas; she has no dominant fixed mass, skin or nipple changes, nipple discharge, or axillary lymphadenopathy. The nodularity is less prominent when she is re-examined on day 7 of her cycle. Which of the following is the most likely diagnosis?
ASolitary breast cyst
BFibrocystic changes
CPhyllodes neoplasm
DBreast fibroadenoma
Reveal answer & full explanation
Correct answer: B — Fibrocystic changes
ASolitary breast cyst
BFibrocystic changes✓
CPhyllodes neoplasm
DBreast fibroadenoma
Why Fibrocystic changes is correct
The hallmark is bilateral, diffuse nodularity (classic "cobblestone" or ropy texture), most prominent in the upper outer quadrants, with cyclic mastalgia that peaks premenstrually and eases with menses.
Changes reflect an exaggerated cyclic response to ovarian estrogen and progesterone; they fluctuate with the cycle, so re-examination in days 5-10 (when changes are minimal) helps distinguish them from a true dominant mass.
Absence of a fixed mass, skin/nipple changes, bloody discharge, and lymphadenopathy is reassuring; this is the most common benign breast condition in reproductive-age women.
Why the others are wrong
Breast fibroadenoma — a discrete, mobile, rubbery, well-circumscribed mass in younger women, not diffuse bilateral cyclic nodularity.
Solitary breast cyst — typically a single round, smooth, sometimes tender mass that is anechoic on ultrasound; presents as a discrete lesion rather than diffuse cobblestone change.
Phyllodes neoplasm — a rapidly enlarging firm unilateral mass spanning a benign-to-malignant spectrum, not painful bilateral cyclic lumpiness.
Question 2ReproductiveEasy
A 34-year-old woman reports several years of bilateral breast lumpiness and tenderness that worsens in the week before each menstrual period and eases once menses begin. On exam there is diffuse, cobblestone nodularity in both upper outer quadrants and a few mildly tender areas, with no dominant mass, skin or nipple changes, or lymphadenopathy. Targeted ultrasound shows scattered simple anechoic cysts and no suspicious solid lesions. Which of the following is the most appropriate initial management?
AExcisional biopsy of the nodular tissue
BOral tamoxifen for mastalgia suppression
CCombined oral contraceptive pills for pain
DReassurance and NSAIDs for symptom relief
Reveal answer & full explanation
Correct answer: D — Reassurance and NSAIDs for symptom relief
AExcisional biopsy of the nodular tissue
BOral tamoxifen for mastalgia suppression
CCombined oral contraceptive pills for pain
DReassurance and NSAIDs for symptom relief✓
Why Reassurance and NSAIDs for symptom relief is correct
This is classic fibrocystic breast change: bilateral, diffuse, cyclic nodularity and mastalgia that tracks the menstrual cycle, with a benign exam and benign imaging (simple anechoic cysts, no suspicious solid lesion).
Once malignancy is excluded by exam and ultrasound, first-line management is reassurance plus supportive measures (a well-fitted supportive bra, warm or cool compresses) and oral or topical NSAIDs for mastalgia.
Fibrocystic changes are a benign, hormonally responsive condition and do not themselves raise breast-cancer risk, so conservative symptom-directed care is appropriate before escalating.
Why the others are wrong
Combined oral contraceptive pills for pain are a second-line option that reduces cyclical pain in some patients, reserved for symptoms persisting despite supportive measures rather than as the first step.
Oral tamoxifen for mastalgia suppression is an off-label option (with danazol) for refractory severe mastalgia, and its significant side-effect profile makes it inappropriate initially.
Excisional biopsy of the nodular tissue is unnecessary when the exam is diffusely benign and imaging shows only simple cysts; sampling is reserved for a discrete suspicious mass, a recurrent or complex cyst, bloody aspirate, or a residual mass after aspiration.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Fibrocystic Breast Changes outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Caffeine and methylxanthine intake (controversial)
Family history
Pathophysiology
Exaggerated cyclic response to ovarian estrogen and progesterone produces stromal proliferation, lobular hyperplasia, and accumulation of fluid in obstructed terminal ductal lobular units → microcyst and macrocyst formation. Most lesions confer no increased cancer risk; atypical hyperplasia (atypical ductal or lobular hyperplasia) does (~4-5x).
Clinical presentation
Symptoms
Bilateral diffuse breast lumpiness, often most prominent in upper outer quadrants
Cyclic breast pain (mastalgia) worse premenstrually, relieved with menses
Palpable cysts that may fluctuate in size with cycle
Generally NOT associated with bloody nipple discharge
Signs / physical exam
Diffuse nodularity, 'cobblestone' texture
Tender areas, especially premenstrually
Discrete cysts may be palpable
No skin or nipple changes; no lymphadenopathy
Differential diagnosis
Breast cancer — Persistent, fixed, irregular mass with skin/nipple changes; imaging and biopsy
Fibroadenoma — Discrete mobile rubbery mass in younger women; well-circumscribed on ultrasound
Simple cyst — Round, anechoic on ultrasound; can aspirate
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.